Back to search

Article

Deubiquitinase USP9X loss Sensitizes Cancer Cells to mTOR Inhibitors through p62 Dysregulation

2021-09-28

Abstract excerpt

<h4>Background: </h4> Mutations in MTOR and TSC1/2 can only explain part of variability in mTOR inhibitor response. Here, we performed a comprehensive molecular characterization of tumors with high sensitivity to these drugs to uncover novel mechanisms of response.MethodsChromophobe renal cell carcinoma (chRCC) tumors were analyzed by whole-exome sequencing. Rapamycin sensitivity, expression of mTOR pathway effect...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e8bae3d5-7ed4-5944-9818-1c50c7432226
DOI
10.21203/rs.3.rs-923880/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Deubiquitinase USP9X loss Sensitizes Cancer Cells to mTOR Inhibitors through p62 DysregulationDOI 10.21203/rs.3.rs-923880/v1
Select a neighboring publication to make it the new centre.